全球動物用藥品配製市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計動物用藥品配製市場將從 2025 年的 31 億美元成長到 2034 年的 67 億美元，2026 年至 2034 年的複合年成長率為 8.93%。

受個人化獸醫護理需求不斷成長以及寵物和牲畜慢性病日益普遍的推動，動物用藥品配製市場正經歷顯著成長。隨著寵物飼養量的增加和動物健康意識的提高，獸醫擴大轉向配製藥房，以配製滿足個別動物特定需求的定製藥物。當非處方藥因劑量、劑型或口味偏好等原因不適用時，這種趨勢尤其明顯。定製藥物的能力提高了遵守用藥，使動物用藥品配製市場成為現代獸醫護理的關鍵組成部分。

此外，製藥技術和法規結構的進步正在推動獸用複方製劑市場的成長。更嚴格的品質標準和指南的實施確保了複方製劑的安全、有效和可靠。隨著獸醫專業人員對複方製劑益處的認知不斷加深，預計市場將進一步擴大，越來越多的獸醫診所將複方製劑服務納入其診療範圍。此外，遠端醫療在獸醫領域的興起也為複方製劑藥局創造了新的機遇，使其能夠觸達更廣泛的客戶群體，實現遠距諮詢和個人化藥物配送。

動物用藥品配製市場也在製劑技術方面不斷創新，致力於開發新的給藥方式，以提高藥物的偏好和療效。添加香料、經皮系統以及緩釋製劑的引入，只是配製藥房為滿足獸醫學不斷變化的需求而採取的幾種方式。隨著市場在消費者需求、技術進步和監管支持的共同推動下持續成長，動物配製藥的未來有望保障動物的健康和福祉，並提高醫療照護品質。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球動物用藥品配製市場（以動物類型分類）

• 市場分析、洞察與預測
• 伴侶動物
• 家畜

5. 全球動物用藥品配製市場（依藥物類型分類）

• 市場分析、洞察與預測
• 抗感染劑
• 抗發炎藥
• 荷爾蒙及其替代品
• 中樞神經系統藥物
• 其他藥物類型

6. 全球動物用藥品複方製劑市場（以劑型分類）

• 市場分析、洞察與預測
• 口服藥物（片劑、膠囊、液體和其他口服藥物）
• 外用藥物（軟膏、乳霜、凝膠、噴霧）
• 注射
• 其他劑型

7. 全球動物用藥品配製劑市場（依分銷管道分類）

• 市場分析、洞察與預測
• 獸醫診所和藥房
• 配藥藥房
• 其他分銷管道

8. 全球動物用藥品配藥市場（按地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AVRIO Pharmacy
  • New Era Pharmacy
  • NexGen Pharmaceuticals
  • Pace Pharmacy
  • SaveWay Compounding Pharmacy
  • ScriptWorks
  • SCIRx Pharmacy
  • Summit Veterinary Pharmacy Ltd
  • Triangle Compounding Pharmacy
  • The Pet Apothecary
  • Veterinary Pharmaceutical Solutions
  • Veterinary Specialty Pharmacy
  • Wedgewood Pharmacy

The Animal Drug Compounding Market size is expected to reach USD 6.70 Billion in 2034 from USD 3.10 Billion (2025) growing at a CAGR of 8.93% during 2026-2034.

The animal drug compounding market is experiencing a notable surge, driven by the increasing demand for personalized veterinary care and the growing prevalence of chronic diseases in pets and livestock. As pet ownership rises and animal health awareness grows, veterinarians are increasingly turning to compounding pharmacies to create tailored medications that meet the specific needs of individual animals. This trend is particularly significant in cases where commercially available drugs may not be suitable due to dosage, formulation, or flavor preferences. The ability to customize medications enhances treatment efficacy and compliance, positioning the animal drug compounding market as a vital component of modern veterinary practice.

Furthermore, advancements in pharmaceutical technology and regulatory frameworks are facilitating the growth of the animal drug compounding market. The introduction of more stringent quality standards and guidelines is ensuring that compounded medications are safe, effective, and reliable. As veterinary professionals become more educated about the benefits of compounded drugs, the market is likely to expand, with an increasing number of veterinary practices incorporating compounding services into their offerings. Additionally, the rise of telemedicine in veterinary care is creating new opportunities for compounding pharmacies to reach a broader clientele, allowing for remote consultations and customized medication delivery.

The animal drug compounding market is also witnessing innovation in formulation techniques, with a focus on developing new delivery methods that enhance the palatability and efficacy of medications. The incorporation of flavoring agents, transdermal delivery systems, and sustained-release formulations are just a few examples of how compounding pharmacies are adapting to meet the evolving needs of veterinary medicine. As the market continues to grow, driven by a combination of consumer demand, technological advancements, and regulatory support, the future of animal drug compounding promises to enhance the quality of care for animals, ensuring their health and well-being.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal Type

• Companion Animals
• Livestock Animals

By Drug Type

• Anti-Infective Agents
• Anti-Inflammatory Agents
• Hormones & Substitutes
• CNS Agents
• Other Drug Types

By Dosage Form

• Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms)
• Topical (Ointments, Creams, Gels, Sprays)
• Injectable
• Other Dosage Forms

By Distribution Channel

• Veterinary Hospitals Pharmacies
• Compounding Pharmacies
• Other Distribution Channels

COMPANIES PROFILED

• AVRIO Pharmacy, New Era Pharmacy, NexGen Pharmaceuticals, Pace Pharmacy, SaveWay Compounding Pharmacy, ScriptWorks, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd, Triangle Compounding Pharmacy, The Pet Apothecary, Veterinary Pharmaceutical Solutions, Veterinary Specialty Pharmacy, Wedgewood Pharmacy

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Drug Type
• 5.2. Anti-Infective Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Anti-Inflammatory Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hormones & Substitutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CNS Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Drug Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DOSAGE FORM 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Dosage Form
• 6.2. Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Topical (Ointments, Creams, Gels, Sprays) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Dosage Forms Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospitals Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Compounding Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Animal Type
  • 8.2.2 By Drug Type
  • 8.2.3 By Dosage Form
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Animal Type
  • 8.3.2 By Drug Type
  • 8.3.3 By Dosage Form
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Animal Type
  • 8.4.2 By Drug Type
  • 8.4.3 By Dosage Form
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Animal Type
  • 8.5.2 By Drug Type
  • 8.5.3 By Dosage Form
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Animal Type
  • 8.6.2 By Drug Type
  • 8.6.3 By Dosage Form
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ANIMAL DRUG COMPOUNDING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AVRIO Pharmacy
  • 10.2.2 New Era Pharmacy
  • 10.2.3 NexGen Pharmaceuticals
  • 10.2.4 Pace Pharmacy
  • 10.2.5 SaveWay Compounding Pharmacy
  • 10.2.6 ScriptWorks
  • 10.2.7 SCIRx Pharmacy
  • 10.2.8 Summit Veterinary Pharmacy Ltd
  • 10.2.9 Triangle Compounding Pharmacy
  • 10.2.10 The Pet Apothecary
  • 10.2.11 Veterinary Pharmaceutical Solutions
  • 10.2.12 Veterinary Specialty Pharmacy
  • 10.2.13 Wedgewood Pharmacy